Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-acting semaglutide implant under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results